BRCA1 protein products: Antibody specificity von Wilson, Cindy A, Payton, Marc N, Pekar, Susan K, Zhang, Ke, Pacifici, Robert E, Gudas, Jean L, Thukral, Sushil, Calzone, Frank J, Reese, David M, Slamon, Dennis I

Volltext

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses von Chiappinelli, Katherine B., Strissel, Pamela L., Desrichard, Alexis, Li, Huili, Henke, Christine, Akman, Benjamin, Hein, Alexander, Rote, Neal S., Cope, Leslie M., Snyder, Alexandra, Makarov, Vladimir, Buhu, Sadna, Slamon, Dennis J., Wolchok, Jedd D., Pardoll, Drew M., Beckmann, Matthias W., Zahnow, Cynthia A., Merghoub, Taha, Chan, Timothy A., Baylin, Stephen B., Strick, Reiner

Volltext

Moving from Cancer Genetics to Therapy

Volltext

Palbociclib and Letrozole in Advanced Breast Cancer von Finn, Richard S, Martin, Miguel, Rugo, Hope S, Jones, Stephen, Im, Seock-Ah, Gelmon, Karen, Harbeck, Nadia, Lipatov, Oleg N, Walshe, Janice M, Moulder, Stacy, Gauthier, Eric, Lu, Dongrui R, Randolph, Sophia, Diéras, Véronique, Slamon, Dennis J

Volltext

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers von Finn, Richard S, Aleshin, Alexey, Slamon, Dennis J

Volltext

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 von Slamon, Dennis J, Neven, Patrick, Chia, Stephen, Fasching, Peter A, De Laurentiis, Michelino, Im, Seock-Ah, Petrakova, Katarina, Bianchi, Giulia Val, Esteva, Francisco J, Martín, Miguel, Nusch, Arnd, Sonke, Gabe S, De la Cruz-Merino, Luis, Beck, J Thaddeus, Pivot, Xavier, Vidam, Gena, Wang, Yingbo, Rodriguez Lorenc, Karen, Miller, Michelle, Taran, Tetiana, Jerusalem, Guy

Volltext

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro von Finn, Richard S, Dering, Judy, Conklin, Dylan, Kalous, Ondrej, Cohen, David J, Desai, Amrita J, Ginther, Charles, Atefi, Mohammad, Chen, Isan, Fowst, Camilla, Los, Gerret, Slamon, Dennis J

Volltext

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer von Turner, Nicholas C, Slamon, Dennis J, Ro, Jungsil, Bondarenko, Igor, Im, Seock-Ah, Masuda, Norikazu, Colleoni, Marco, DeMichele, Angela, Loi, Sherene, Verma, Sunil, Iwata, Hiroji, Harbeck, Nadia, Loibl, Sibylle, André, Fabrice, Puyana Theall, Kathy, Huang, Xin, Giorgetti, Carla, Huang Bartlett, Cynthia, Cristofanilli, Massimo

Volltext

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, ad... von Finn, Richard S, MD, Crown, John P, Prof, Lang, Istvan, MD, Boer, Katalin, MD, Bondarenko, Igor M, Prof, Kulyk, Sergey O, MD, Ettl, Johannes, MD, Patel, Ravindranath, MD, Pinter, Tamas, MD, Schmidt, Marcus, MD, Shparyk, Yaroslav, MD, Thummala, Anu R, MD, Voytko, Nataliya L, MD, Fowst, Camilla, MD, Huang, Xin, PhD, Kim, Sindy T, BS, Randolph, Sophia, MD, Slamon, Dennis J, Prof

Volltext

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer von KONECNY, Gottfried E, CHEN WANG, GOSTOUT, Bobbie, PODRATZ, Karl C, KEENEY, Gary, WANG, He-Jing, HARTMANN, Lynn C, SLAMON, Dennis J, GOODE, Ellen L, HAMIDI, Habib, WINTERHOFF, Boris, KALLI, Kimberly R, DERING, Judy, GINTHER, Charles, CHEN, Hsiao-Wang, DOWDY, Sean, CLIBY, William

Volltext

Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer von O'Brien, Neil A, McDermott, Martina S J, Conklin, Dylan, Luo, Tong, Ayala, Raul, Salgar, Suruchi, Chau, Kevin, DiTomaso, Emmanuelle, Babbar, Naveen, Su, Faye, Gaither, Alex, Hurvitz, Sara A, Linnartz, Ronald, Rose, Kristine, Hirawat, Samit, Slamon, Dennis J

Volltext

Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy von Zoeller, Jason J, Press, Michael F, Selfors, Laura M, Dering, Judy, Slamon, Dennis J, Hurvitz, Sara A, Brugge, Joan S

Volltext

Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer von Pegram, Mark D., Konecny, Gottfried E., O'Callaghan, Carminda, Beryt, Malgorzata, Pietras, Richard, Slamon, Dennis J.

Volltext

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer von Slamon, Dennis J, Neven, Patrick, Chia, Stephen, Fasching, Peter A, De Laurentiis, Michelino, Im, Seock-Ah, Petrakova, Katarina, Bianchi, Giulia V, Esteva, Francisco J, Martín, Miguel, Nusch, Arnd, Sonke, Gabe S, De la Cruz-Merino, Luis, Beck, J. Thaddeus, Pivot, Xavier, Sondhi, Manu, Wang, Yingbo, Chakravartty, Arunava, Rodriguez-Lorenc, Karen, Taran, Tetiana, Jerusalem, Guy

Volltext

Ribociclib plus Fulvestrant in Advanced Breast Cancer. Reply von Slamon, Dennis J, Jerusalem, Guy

Volltext

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations von SAUTER, Guido, LEE, James, BARTLETT, John M. S, SLAMON, Dennis J, PRESS, Michael F

Volltext

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study von Cristofanilli, Massimo, Rugo, Hope S, Im, Seock-Ah, Slamon, Dennis J, Harbeck, Nadia, Bondarenko, Igor, Masuda, Norikazu, Colleoni, Marco, DeMichele, Angela, Loi, Sherene, Iwata, Hiroji, O'Leary, Ben, André, Fabrice, Loibl, Sibylle, Bananis, Eustratios, Liu, Yuan, Huang, Xin, Kim, Sindy, Lechuga Frean, Maria Jose, Turner, Nicholas C

Volltext

Cycling cancer persister cells arise from lineages with distinct programs von Oren, Yaara, Tsabar, Michael, Cuoco, Michael S., Amir-Zilberstein, Liat, Cabanos, Heidie F., Hütter, Jan-Christian, Hu, Bomiao, Thakore, Pratiksha I., Tabaka, Marcin, Fulco, Charles P., Colgan, William, Cuevas, Brandon M., Hurvitz, Sara A., Slamon, Dennis J., Deik, Amy, Pierce, Kerry A., Clish, Clary, Hata, Aaron N., Zaganjor, Elma, Lahav, Galit, Politi, Katerina, Brugge, Joan S., Regev, Aviv

Volltext

Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum von Fejzo, Marlena S., Sazonova, Olga V., Sathirapongsasuti, J. Fah, Hallgrímsdóttir, Ingileif B., Vacic, Vladimir, MacGibbon, Kimber W., Schoenberg, Frederic P., Mancuso, Nicholas, Slamon, Dennis J., Mullin, Patrick M.

Volltext

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR + /HER2 - Breast Cancer von Hurvitz, Sara A, Martin, Miguel, Press, Michael F, Chan, David, Fernandez-Abad, María, Petru, Edgar, Rostorfer, Regan, Guarneri, Valentina, Huang, Chiun-Sheng, Barriga, Susana, Wijayawardana, Sameera, Brahmachary, Manisha, Ebert, Philip J, Hossain, Anwar, Liu, Jiangang, Abel, Adam, Aggarwal, Amit, Jansen, Valerie M, Slamon, Dennis J

Volltext